Latest Rights Issue News

Identitii Limited launches a $2.9 million rights issue, underwritten up to $2.3 million by its largest shareholder, to accelerate the commercial rollout of its BNDRY platform.

HITIQ Limited has successfully raised $925,000 through an oversubscribed placement, issuing shares at a discount and attaching listed options to support its concussion management technology's commercialisation.

APC Minerals Limited has initiated a fully underwritten pro-rata renounceable entitlement offer to raise approximately $1.38 million at $0.004 per share, aiming to fund its exploration projects and working capital needs.

Clara Resources has successfully placed over 300 million shortfall shares from its recent rights issue, raising nearly $1 million to accelerate development at its Ashford Coking Coal Project and explore new opportunities.

Pathkey.AI has secured A$2.5 million through a placement and launched a nearly A$1 million rights issue to fund expansion of its AI-driven TrialKey platform and pursue strategic acquisitions, alongside key board changes.

InhaleRx Limited has introduced SRX-25, an oral fixed-dose combination therapy targeting Treatment-Resistant Depression, aiming to improve patient access and adherence. The company also secured $1 million in capital to advance clinical development and plans a strategic rebrand.

A former director of Emu NL has lodged a formal application with the Takeovers Panel, contesting the legitimacy of a recent $1.4 million institutional placement and alleging undisclosed attempts to influence board control.

Metro Performance Glass Limited has returned to profitability in the first half of 2025, posting a NZD 4.5 million profit before tax and significantly reducing its debt through a NZD 23.9 million equity raise.

Askari Metals has successfully closed an oversubscribed rights issue raising approximately $1.6 million to accelerate exploration at its promising Nejo Gold and Copper Project in Ethiopia and the Uis Project in Namibia.

Mt Malcolm Mine NL has supplemented its October Rights Issue with a $750,000 Placement Offer, updating its capital structure and funding plans to accelerate exploration and repay director loans.

Mt Malcolm Mines has successfully closed an oversubscribed $2.3 million rights issue and secured an additional $750,000 placement, positioning the company to fast-track exploration and development at its Malcolm Gold Project.

Biotron Limited has launched a $1.5 million non-renounceable rights issue to fund its strategic acquisition of Sedarex Limited and support ongoing drug development programs. The capital raise follows shareholder approval and aims to diversify Biotron’s portfolio with a next-generation general anaesthetic.